1-3 of 3
John C. Byrd
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

Dimitrios Papaioannou, Deedra Nicolet, Hatice G. Ozer, Krzysztof Mrózek, Stefano Volinia, Paolo Fadda, Andrew J. Carroll, Jessica Kohlschmidt, Jonathan E. Kolitz, Eunice S. Wang, Richard M. Stone, John C. Byrd, Ramiro Garzon, Clara D. Bloomfield
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (8): 1451–1459.
https://doi.org/10.1158/1535-7163.MCT-18-1125
Published: 01 August 2019
View article titled, Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia
Open the PDF for Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma

Andrew Stiff, Enrico Caserta, Douglas W. Sborov, Gerard J. Nuovo, Xiaokui Mo, Sarah Y. Schlotter, Alessandro Canella, Emily Smith, Joseph Badway, Matthew Old, Alena Cristina Jaime-Ramirez, Pearlly Yan, Don M. Benson, John C. Byrd, Robert Baiocchi, Balveen Kaur, Craig C. Hofmeister, Flavia Pichiorri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (5): 830–841.
https://doi.org/10.1158/1535-7163.MCT-15-0240-T
Published: 05 May 2016
View article titled, Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
Open the PDF for Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract B44: Pharmacologic inhibition with IPI-145 and genetic inhibition of PI3K p110δ antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia

Amy J. Johnson, Shuai Dong, Daphne Guinn, Jason A. Dubovsky, Yiming Zhong, Amy Lehman, Jeff Kutok, Jennifer A. Woyach, John C. Byrd
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): B44.
https://doi.org/10.1158/1538-8514.PI3K14-B44
Published: 06 July 2015
View article titled, Abstract B44: Pharmacologic inhibition with IPI-145 and genetic inhibition of PI3K p110δ antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia